glp-1 for iih Association between receptor agonist use and neurosurgical intervention in patients with idiopathic intracranial hypertension and obesity: a propensity-matched, multi-institutional, cohort study The effect of glucagon-like peptide-1

Medical supervision ensures proper dosing, purity verification, and ongoing monitoring for maximum benefit and minimal risk

Is eating behavior manipulated by the gastrointestinal microbiota

The Risks of Responding "Too Well" Being a super responder sounds like a win, but losing weight at an extreme speed carries medical risks

Jamie Bennett, a spokesperson for Wegovy and Ozempic maker Novo Nordisk, declined to comment on the concept of deprescription, noting that its drugs are intended for chronic conditions

Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis

By working together, we strive to help you manage your symptoms and improve your overall well-being